Larimar Therapeutics, Inc. (LRMR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Larimar Therapeutics, Inc. (LRMR)
Go deeper and ask any question about LRMR
Company Performance
Current Price
as of Sep 13, 2024$7.20
P/E Ratio
N/A
Market Cap
$459.41M
Description
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Metrics
Overview
- HQBala Cynwyd, PA
- SectorHealth Technology
- IndustryBiotechnology
- TickerLRMR
- Price$7.2-0.55%
Trading Information
- Market Cap$459.41M
- Float58.42%
- Average Daily Volume (1m)410,500
- Average Daily Volume (3m)514,189
- EPS-$1.11
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$21.63M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$24.51M
- EV$242.09M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings